Related Experiment Video

Updated: Aug 1, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Hepatitis C virus infection

B J Thomson1, R G Finch

  • 1Department of Infectious Diseases, University of Nottingham, Nottingham, UK. brian.thomson@nottingham.ac.uk

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|February 1, 2005
PubMed

Insights

Hepatitis C virus (HCV) infection affects millions globally, leading to chronic liver disease. This review covers HCV

Area of Science:

  • Hepatology and Virology

Background:

  • Hepatitis C virus (HCV) infection is a significant global health concern, with up to 3% of the world's population infected.
  • Chronic HCV infection affects 80% of exposed individuals, increasing the risk of severe liver conditions like cirrhosis and cancer.
  • The UK has a substantial burden, with at least 200,000 adults carrying the virus.

Purpose of the Study:

  • To provide a comprehensive overview of Hepatitis C virus (HCV) molecular biology and pathogenesis.
  • To detail the epidemiology, hepatic and extra-hepatic manifestations of HCV.
  • To discuss current treatment strategies for acute and chronic HCV infections.

Main Methods:

  • This is a review article, synthesizing existing research and data on HCV.
  • It covers molecular biology, pathogenesis, epidemiology, clinical manifestations, and treatment options.
  • Special populations including healthcare workers, prisoners, and HIV-coinfected individuals are specifically addressed.

Main Results:

  • HCV infection has profound molecular and pathogenic effects, leading to significant liver disease.
  • The virus causes both liver-specific (hepatic) and other organ (extra-hepatic) diseases.
  • A range of treatment options are available for both acute and chronic phases of HCV infection.

Conclusions:

  • Understanding HCV's biology, spread, and impact is crucial for public health.
  • Comprehensive management strategies are essential for controlling HCV-related morbidity and mortality.
  • Targeted approaches are needed for high-risk and coinfected populations.

More Related Videos

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis10:23

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis

Published on: April 17, 2017

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Related Concept Videos

Yellow Fever01:18

Yellow Fever

Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...